PREDICTIV.ONCOLOGY DL-,01
PREDICTIV.ONCOLOGY DL-,01
Action · US74039M3097 · POAI · A2QPFZ (XNCM)
Aperçu Indicateurs financiers
0,82 EUR
-1,06 % -0,009 EUR
Frankfurt (XNAS) · Cours et graphiques actuels sur MoneyPeak
06.06.2025 19:59

Cours actuels de PREDICTIV.ONCOLOGY DL-,01

BourseTickerDeviseDernier échangeCoursVariation journalière
XNAS: NASDAQ
NASDAQ
POAI
USD
06.06.2025 19:59
0,93 USD
0,93 USD
-0,20 %

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
-0,49 % 7,44 % -8,83 % -21,76 % 9,95 % -27,14 % -97,34 %

Profil de l'entreprise pour PREDICTIV.ONCOLOGY DL-,01 Action

Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery using active learning technology for discovery, clinical and translational research, clinical trials, and diagnostic development and validation. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using High-Throughput Self-Interaction Chromatography, a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens using additives and excipients that are included in protein formulations for soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates staff exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. It also offers research and development services; and media that help cancer cells grow outside the patient's body and retain their DNA/RNA and proteomic signatures. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota.

Données de l'entreprise

Nom PREDICTIV.ONCOLOGY DL-,01
Société Predictive Oncology Inc.
Symbole POAI
Site web https://www.predictive-oncology.com
Marché d'origine XNCM Frankfurt
WKN A2QPFZ
ISIN US74039M3097
Type de titre Action
Secteur Healthcare
Industrie Medical - Instruments & Supplies
PDG Mr. Raymond F. Vennare
Pays États-Unis d'Amérique
Devise EUR
Employés 0,0 T
Adresse 2915 Commers Drive, 55121 Eagan
Date d'introduction en bourse 2010-05-03

Changements d'identifiant

Date De À
17.06.2019 AIPT POAI

Symboles boursiers

Nom Symbole
NASDAQ POAI

Autres actions

Les investisseurs qui détiennent PREDICTIV.ONCOLOGY DL-,01 ont également les actions suivantes dans leur portefeuille :
CSX CORP 18/68
CSX CORP 18/68 Obligation
PARAGON BANKING 16/26 FLR
PARAGON BANKING 16/26 FLR Obligation
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025